chrisvoncsefalvay/vaers-outcomes huggingface dataset:
anxious; migraine headache; started getting a little tired; fatigued; all of a sudden she wanted to go back to daily routine but she fell asleep in the couch; got nauseated; had chills; fever; broke a sweat; joint pain; muscle pain; it was a little sore on my arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (it was a little sore on my arm), FATIGUE (started getting a little tired), FATIGUE (fatigued), ANXIETY (anxious) and SOMNOLENCE (all of a sudden she wanted to go back to daily routine but she fell asleep in the couch) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included Benadryl for nausea, Tramadol for pain, Tylenol ocassionally for pain, Ativan for panic disorder severe anxiety and PTSD, Risperidone small dose and Andriol for cardiac for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (it was a little sore on my arm). On 18-Mar-2021, the patient experienced FATIGUE (started getting a little tired), FATIGUE (fatigued), SOMNOLENCE (all of a sudden she wanted to go back to daily routine but she fell asleep in the couch), NAUSEA (got nauseated), CHILLS (had chills), PYREXIA (fever), HYPERHIDROSIS (broke a sweat), ARTHRALGIA (joint pain) and MYALGIA (muscle pain). On an unknown date, the patient experienced ANXIETY (anxious) and MIGRAINE (migraine headache). At the time of the report, PAIN IN EXTREMITY (it was a little sore on my arm), FATIGUE (started getting a little tired), FATIGUE (fatigued), NAUSEA (got nauseated), CHILLS (had chills), PYREXIA (fever), HYPERHIDROSIS (broke a sweat), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Metallic taste; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 08Apr2021 at 13:15 (at the age of 44-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had a history of allergy to sulfa. Concomitant medications included montelukast sodium (SINGULAIR) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 13:30, the patient experienced metallic taste after the first dose, the patient reported that it had been almost a month and a half and could taste metal like the first day of the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the event metallic taste was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Dizzy,nausea,headache,general malaise,occ aches,occ head congestion, occ chills but no fever. started afternoon of immunization and continues to present( 3rd day today)
Hearing loss; Vertigo; Tinnitus; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEAFNESS (Hearing loss) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was provided by the reporter.     On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced DEAFNESS (Hearing loss) (seriousness criteria disability and medically significant), VERTIGO (Vertigo) and TINNITUS (Tinnitus). At the time of the report, DEAFNESS (Hearing loss), VERTIGO (Vertigo) and TINNITUS (Tinnitus) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Patient went to audiologist and was given a hearing aide.  Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
new food allergies emerged within a couple of days.  (banana, strawberry, honey).  Now experiencing dysgeusia since the vaccine.  Many foods taste rotten.  It has slightly improved but still very strong alteration in food tastes.
Had a first dose of Moderna but that was several months ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Had a first dose of Moderna but that was several months ago) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Had a first dose of Moderna but that was several months ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Had a first dose of Moderna but that was several months ago) had resolved.            No concomitant medications were provided. Treatment information was not provided.  The patient queried whether it was necessary to receive the second dose and where could the second dose be available in the patient's area.
Pt vaccinated with Pnu-Imune 23/Influenza developed minor rash; MD notified dx serum sickness, temp 100.1 (R); Pt w/vascular macular erythematous eruptions over extensor surfaces large joints. Treatment: Diphenhydramine & APAP.
RASH, HOT, SWOLLEN AND PAINFUL ARM THAT LASTED FOR 3-4 DAYS, PATIENT ALSO MIGHT HAVE EXPERIENCED HER THROAT CLOSING IN BUT WAS NOT SURE IF IT WAS BECAUSE OF ANXIETY.
This case was reported by a physician and described the occurrence of reaction to sulfites in a patient who received Flu Seasonal QIV Dresden for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced reaction to sulfites. On an unknown date, the outcome of the reaction to sulfites was unknown. It was unknown if the reporter considered the reaction to sulfites to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: This case was reported by the patient himself who was a neonatologist. The age at vaccination was not reported. After receiving flu shot, the patient developed a reaction which was recognized as a sulfite sensitivity. The patient asked whether they produce a Flu shot that was free of sulfites, sulfates and any sulfa derivatives.
Continuous crying since immun this AM; Pt given APAP & used compresses but pt continues to scream; 510PM quiet-improved; 30JAN92 TC pt fine no temp and no crying;
Hives; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided
1/27/21 - Very mild shoulder pain shortly after the injection.  Dull headache and very mild fatigue within 15 minutes of vaccine dose. 1/28/21 - Mild shoulder pain all day.  Fatigue and dull headache developed by midday.  99.9-100.0 degrees Farenheit fever around 4pm (temperature remained in this range as measured at 4:30pm, 6:15pm, 8:30pm, and 10:10pm); acetaminophen taken at 4:30pm and 10:10pm before sleep. 1/29/21 - 98.9 degrees Farenheit temperature at 7:30am, but mild runny nose in the morning and mild axillary pain developed by midday.  Mild shoulder pain persisted all day. 1/30/21 - Moderate axillary pain and lymphadenopathy all day.  Mild shoulder pain all day. 1/31/21 - Mild axillary pain.
he felt a sensation under his arm and then today, he checked, and it was swollen; He had Booster shot; Pain injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101758865 (Pfizer).  A 65 year-old male patient received bnt162b2 (BNT162B2), administration date 07Dec2021 (Batch/Lot number: unknown) at the age of 65 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for Covid-19 immunization; Bnt162b2 (Dose: 2), for COVID-19 immunization.  The following information was reported: IMMUNISATION (non-serious) with onset 07Dec2021, outcome "unknown", described as "He had Booster shot"; VACCINATION SITE PAIN (non-serious) with onset 07Dec2021, outcome "unknown", described as "Pain injection site"; PERIPHERAL SWELLING (non-serious) with onset 08Dec2021, outcome "unknown", described as "he felt a sensation under his arm and then today, he checked, and it was swollen".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Discoloration of leg and buttocks. Subsequent blood work revealed antiphospholipid and Sjogren's antibodies. Referral to dermatologist and rheumatologist. Diagnostics and treatment ongoing.
Patient developed a hot red rash over 1/3 of her arm from the HAVRIX immunization within one day. Reaction wasn't severe enough to seek medical attention.
Rash on right shoulder and neck,  itchy, right arm feels numb, tingling right side of neck.  Evaluated by  EMS.  12:24 PM BP 100/80,       HR-80, No c/o scratchy throat.  12:36 pm c/o throat  itching, slight trouble swallowing.   12:40pm reevaluated by EMS.  Breath sounds clear, throat clear.  12:45pm rash essentially gone, continues to  c/o slight itching.  Client offered transportation to hospital-declined.  Client did not feel ER was necessary.   Discharged home at 12:49pm.
The night of receiving the vaccine 7/28/22  I had a low grade fever , next day felt very fatigued, nauseous & had headache.   I considered this normal reaction. However,  these went on for a week, w/the addition of my legs feeling weird, which seemed like too long for side effects.  These symptoms did improve a a bit over the week, & on Sat 8/6/22 during the day I felt like I was finally almost normal. However, Sat evening I suddenly felt very dizzy, had vertigo & was very nauseous.  I had vertigo again on 8/11 and am still very fatigued, with headaches, sinus congestion and leg muscles still feel weird.  Not even close to being able to do normal activities. So I guess I think the adverse event occurred 8/6/22 & forward, but just that the side effects went on so long was also adverse.
3/23: upset stomach; diarrhea. 3/24: severe vomiting and diarrhea. so severe that transported to ER; provided fluids and anti nausea meds and discharged. DX--Viral Gastroenteritis; hyperglycemia. Later that evening experienced seizure and fell out of bed unconscious; suffered shoulder fracture.  Transported to ER again, experienced 2nd seizure en route,  and hospitalized/intubated in ICU.
She feels like awful like her chest, and her stomach and her head was like, all like a lot, her chest and her stomach are cramping up; She feels like awful like her chest, and her stomach and her head was like, all like a lot, her chest and her stomach are cramping up; She feels like awful like her chest, and her stomach and her head was like, all like a lot, her chest and her stomach are cramping up; She feels like awful like her chest, and her stomach and her head was like, all like a lot, her chest and her stomach are cramping up; She feels like awful like her chest, and her stomach and her head was like, all like a lot, her chest and her stomach are cramping up; She was like experiencing a lot of diarrhea and like vomiting stuff; She was like experiencing a lot of diarrhea and like vomiting stuff; She could not even move; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). This consumer (patient child) reported for patient. A 42-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Sep2021 10:30 (Lot number: 301308A) at the age of 42 years as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), HEAD DISCOMFORT (non-serious), CHEST DISCOMFORT (non-serious), ABDOMINAL PAIN UPPER (non-serious), MUSCLE SPASMS (non-serious), outcome "unknown" and all described as "She feels like awful like her chest, and her stomach and her head was like, all like a lot, her chest and her stomach are cramping up"; DIARRHOEA (non-serious), VOMITING (non-serious), outcome "unknown" and all described as "She was like experiencing a lot of diarrhea and like vomiting stuff"; MOVEMENT DISORDER (non-serious), outcome "unknown", described as "She could not even move".  Additional information: No other products. No patient history. No investigation assessment. Reporter stated patient went yesterday to get her shot and today she woke up and she feels like awful like her chest, and her stomach and her head was like, all like a lot, her chest and her stomach are cramping up and she was like experiencing a lot of diarrhea and like vomiting stuff. She was really fine that was being happening until yesterday. Was calling to see like if there was something she could take that may be like you know call outside effect of this. This really a lot like she could not even move.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a physician refers to a 4 month old patient of unknown gender. The patient's concurrent conditions, concomitant medications, pertinent medical history and drug reactions or allergies were not provided. On 28-AUG-2017, the patient was vaccinated with an improperly stored dose of PEDVAXHIB, lot # N000235 with expiration date on 26-OCT-2019 (dose and route of administration were not reported). Since 21-JUN-2017, the administered dose of PEDVAXHIB underwent multiple temperature excursions between 32 degrees Fahrenheit and 49 degrees Fahrenheit, which lasted for 16 hours. A digital data logger was not involved in recording the excursion. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012766.
15 year old received first dose of Moderna; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received first dose of Moderna) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Peanut allergy. Concomitant products included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for an unknown indication.    On 07-Feb-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Feb-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received first dose of Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received first dose of Moderna) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. The nurse accidentally gave a 0.5 ml dose of Moderna to a 15-year-old male patient. Patient had no reactions. Patient had never tested positive for COVID-19. No treatment medication was provided.
VACCINE FIRST DOSE WAS GIVEN ON January 6th. first days sore left arm, to painful to lie on, little feverish feeling but no fever for 3 days. After this no symptoms and all felt fine. on January 14th in the afternoon, left side, neck painful muscles, January 16th same painful muscles and around clavicle swollen lymphnode, left side shoulder and top of back sore muscles and left arm feels a bit numb and hand feels a bit colder than right hand. I do not have any redness, no fever, just lymphnode(s) and painful muscles in left side neck and back of left shoulder.
Rash starting on right cheek of face spreading all over the body except center of back.  Rash was RED, bumpy, itching and stinging was absolutely horrible.  Call Dr. on February 1 and received hydroxyzine 25mg (1 every 6 hrs.) from pharmacy.  Made Dr. apt for Tuesday Feb 2 at 1:30.  Dr. gave steroid shot in right hip and RX for Prednisone for 1/Day.   On Thursday, Feb. 4 I was no better.  Dr. upped dosage from 1 tablet to 2 on both RX's and added RX for Montelukast to take in the afternoon.  On Saturday, Feb. 6 my throat was closing up and I was seeing dark spots, but did not pass completely.  Medics called and checked vitals determining cause was from dehydration.  I was very tired throughout the course of this rash, itching and stinging.  I began to see a small improvement on Monday, February 8, 2021 with a little improvement each day.  I still have some visual signs of rash on my chest, breasts, and stomach, but the itching is much better and the stinging is gone.  That's all.
Patient felt dizziness post Covid vaccine.  11:30 128/82 68 pulse 13 respirations. 12:00 130/78, 66, 16 ER precautions discussed, pt going directly home, will self monitor, mother at same household, discharged at 12:00.
This 74 year old male received the Covid shot on  3/2/21    and went to the ED on  4/23/21     and was admitted  on 4/23/21 with the following diagnoses listed below. D69.6 - Thrombocytopenia, unspecified
Approximately 22 hours after getting vaccinated, started having chest pain in the middle of chest.  Checked BP couple hours later, 215/110, decided to go to ER. Admitted to step down unit on 3/2/23. About 5 am on 3/3/23 started having heart attack. Had heart cath same day and "they used a balloon to open the stents that were originally placed in 2016".  Released from hospital on 3/6/23 to follow up with cardiologist.
Information has been received from a registered nurse concerning a 12 or 13 year old female patient who it is believed in around 1996 was vaccianted SC with a 0.5 ml dose of varicella virus vaccine live, lot number unknown. The reporter mentioned that the child came into the office over the past week (approximately 5/11/2005) with a breakthrough case of chickenpox. The child had 50 or less lesions. There was no other information available regarding the adverse event or the patients outcome. There was no product quality complaint reported. Additional information has been requested.
Mother believes that the rash began after receiving the Hep B immunization. No bleeding or pus. Afebrile, not acutely ill.
1 day p/got gen sick, earache, ears plugged;p/a few more days trouble hearing, ringing in ears, back pain, pain all over;went to MD 13NOV (2wk later) on 14th while @ lung @ school felt like was going to black out;dx GBS
SHORT OF BREATH, EXPOSURE TO WIFE WITH covid, FEVER, ADMITTED TO ICU AND THEN HOSPICE
I was given the vaccine at 3:10 immediately, the nurse disposed the vaccine in the sharp container, I saw her 4 times then my face became numb and at 3:40 pm I collapsed in the center according to the notes taken by the Emergency Room. I was transported by ambulance and hospitalized at the from February 25 to 28. I am currently being evaluated by a Neurologist and Cardiologist, primary medical follow-up.
I had my vaccine (Pfizer covid booster) on February 5th.  On February 6th, my neck started clicking and was somewhat swollen and painful on the left side (my vaccination was in the right arm).    I have had a subsequent xray, ultrasound and mri of my neck, paying particular attention to that swollen area on the left where the clicking is.  All tests have been negative.  It is not a lymph node.    It is now June (4 months later) and my neck is still swollen, painful and clicking on the left side.  My muscles are extremely tight.  It is not clear to me what happened but perhaps some kind of inflammatory response.  It is somewhat better-- I can turn my head without so much pain now and I can turn it further.  But I've been undergoing both physical therapy and chiropractic treatment.
An itchy, blotchy red rash and small red bumps appeared on my arms, neck, and abdomen approximately 30 minutes after injection. The injection site was sore and warm to the touch. I took 25mg of diphenhydramine approximately 35 minutes after injection, with some relief of symptoms. Symptoms had totally cleared at approximately 4:00pm the same day.
first dose in 2019 has not received dose two; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 03-May-2022 Reporter's comment: Pharmacist reported that a patient had not received dose two. Consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
SHORT OF BREATH AND WHEEZING, WITHIN  MINUTES OF VACCINATION.  SELF ADMINISTERD EPI TO  EMERGENCY DEP 1458 DISCHARGED 1938. IV FLUIDS, EPI, FAMOTIDINE, METHYLPREDNISONE, DYPHENHYDRAMINE.
Patient recieved dose 1 of the SHINGRIX in the right arm. Complains of swollen lump near injection site. Neck pain along with a small rash.